Navigation Links
Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Date:1/31/2008

tstanding.

Interest expense, net of capitalized interest and taxes was $10,331

and $33,948 for the 2007 fourth quarter and full year, respectively,

compared with $8,168 and $30,009 for the 2006 fourth quarter and full

year, respectively.

(3) Charges related to activities associated with the Company's

productivity initiatives and the 2006 income tax adjustment are

considered certain significant items and have been excluded from the

results of operations -- as adjusted for the 2007 and 2006 fourth

quarter and full year as follows:

Productivity Initiatives

(UNAUDITED)

Three Months Ended Full Year Ended

(In thousands, except 12/31/07 12/31/06 12/31/07 12/31/06

per share amounts)

Cost of Goods Sold $62,000 $42,700 $244,300 $129,200

Selling, General and

Administrative Expenses 1,900 23,200 28,800 78,000

Research and Development

Expenses - (2,100) 300 11,400

Total Productivity

Initiatives Charges $63,900 $63,800 $273,400 $218,600

Productivity Initiatives

Charges, After-tax $41,900 $48,100 $194,400 $154,500

Decrease in Diluted

Earnings per Share $0.03 $0.03 $0.14 $0.11

Income Tax Adjustment

The 2006 full year results include an income tax adjustment of $70.4

million ($0.05 per share-diluted) related to the reduction of certain

deferred tax asset valuation allowances.

Wyeth calculates net income before certain significant items by excluding the after-tax effect of items considered by management to be unusual from the net income reported under gene
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
2. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
3. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
4. Wyeth Announces Election of New Principal Corporate Officer
5. Wyeth Declares Preferred Stock Dividend
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...HOPKINTON, Mass., Dec. 3 ...eading provider of tools and services for drug dis...d Living Image 4.0 software for IVIS® in vivo... more than 800 Caliper IVIS systems currently inst...features advanced spectral unmixing tools to enhan...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Carbondioxide...http://www.reportlinker.com/p0164368/Carbondioxide..., Incubators are the most critical equipment us...d other applications for providing a controlled en...
(Date:12/2/2009)..., CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onco...) (TSX:ONC; NASDAQ: ONCY ) announced today that in...ering, the underwriters have exercised in full the...al 637,500 units. Each unit is comprised of one co...ant, and was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Lt...oral JAK2 inhibitor, SB1518, at The American Socie...n in New Orleans. ,, Data will be presented on ...ion trial of SB1518 detailing its safety, tolerabi...rofile in dose levels ranging from 100 to 600 mg. ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...May Minimize Viral Transmission, Including Norovir...zer may significantly impact public health by mini...ding norovirus, from food handlers and care provid...a, Ontario, Canada, and North Carolina State Unive... 2008 issue of the journal Applied and Environmen...
...iversity researcher has created a compound that pr...nd could lead to a treatment for the disease. , "...aths and thousands of illnesses, and there is curr...rofessor that led the molecular design team. "Alth...ncern that SARS could return or be used as a biolo...
...Sensors & Controls™ (Gems), a global lea...iniature solenoid valves, and fluidic systems has ...nsors. The UCL-520 Series is suitable for non-cont...t, wastewater management, chemical storage as well... Plainville, CT (Vocus) Dec...
Other Biology Technology:Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3GEMS Introduces Ultrasonic Continuous Liquid Level Sensor for Challenging Fluid Measurement 2
(Date:12/4/2009)..., A major discovery is challenging accepted thinki...sociated with diseases such as Alzheimer,s and Par... therapeutics. , It was believed that amyloid fi...ometimes known as fibres - are inert, but that the...h can damage cells and cause disease. , But in ...
(Date:12/3/2009)..., Our ability to learn new information and adapt t...retain lifelong memories, appears to lie in the mi...rding to a new study by NYU Langone Medicine Cente...week in the journal Nature . , The scientists,...physiology and neuroscience at NYU School of Medic...
(Date:12/3/2009)...Contents of this message: , , Preliminary Pre...p to California Academy of Sciences museum, Atte..., NCSWA holiday dinner registration deadline 10..., News Media Registration Form pre-registration d... , For important information regarding visas fo...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 1Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 2Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
...prehensive national study of how carbon dioxide em...isheries, marine mammals, coral reefs, and other n... the National Science Foundation. , "Carbon diox...ng of fossil fuels is not only contributing to atm...ski, director of scientific programs and chief sci...
... Ariz. Oct. 21, 2008 TGen has spun off its third...ical information source for oncologists. , The fo...a variety of data sources, including genetic-based...sed Translational Genomics Research Institute. , ...ncologists with the knowledge they need to design ...
... New South Wales (UNSW) research has highlighted a...t before and during pregnancy. The work in animals... likely to have babies with more body fat, who are...isorders later in life. , Previous research shows...nt are overweight. , The research, published in t...
Other Biology News:NOAA and NSF commission national study of ocean acidification 2TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2Overweight mums have chubby bubs 2
... clone 8G8/5 GenBank Accession Number : NM_002542...ma fusion protein corresponding to residues 166-22...an AP-2γ Formulation: 0.1M Tris-glycine, pH ...ition of glycerol to 30% Quality Assurance: routin...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
...the caudal-related homeobox family, is an intestin...h proliferation and differentiation in intestinal ...iggering cells towards the phenotype of differenti...nce of the phenotype. Clone CDX2-88 reacts with a ...
Biology Products: